House hearing on vaccine safety systems - Interview with Dr David Wiseman

Assessing America’s Vaccine Safety Systems, Part 1. Select Subcommittee on the Coronavirus Pandemic, February 15, 2024

Dr. David Wiseman is a PhD Bioscientist with a background in pharmacy, pharmacology, immunology and experimental pathology. He was in the top echelon of research scientists at Johnson & Johnson, heading a preclinical and clinical R&D program, includnig pharmacovigilance and FDA submissions in the area of postsurgical adhesions. He has been a peer and Cochrane reviewer. Since 1996 he has run his own medical product R&D consulting business. He co-founded the world’s first clinic for the integrated treatment of pelvic and abdominal pain and pioneered the use of a device for those conditions.
Dr. Wiseman has focused on Covid-19 since 2020. His analyses have overturned studies used to justify public policy regarding hydroxychloroquine and ivermectin. He has made over 28 submissions on Covid-19 vaccines to government bodies including FDA, CDC and NIH. He is a contributor to Trial Site News and participated in Senator Johnson’s two expert panels in 2022.